ENGLISH
Abbott Header Logo
Logo Image

Breaking down

Barriers in

Healthcare

Read the white paper
Breaking down banner image
Breaking down banner image
Breaking down banner image

Today's challenges
Are tomorrow's opportunities

Breaking Down Barriers in Healthcare: An Urgency for the Clinical Laboratory to Move to the Forefront of Patient Care draws on extensive global research that indicates healthcare executives are ready to integrate their laboratories into plans for value-based healthcare.

Read the white paper, developed in partnership with The Economist, to learn about the underlying forces within healthcare and society that are driving change, and how to recognize the benefits of proactively managing this change.

Read the white paper
Chapters at a glance

Chapter 1

Nature of the Problem

Learn why value-based healthcare initiatives have slowed, but opportunities remain for the laboratory to grow.

Chapter 2

Clinical Laboratories Today

Discover the challenges that can prevent the laboratory from enhancing its role in the healthcare system.

Chapter 3

Opportunities & Challenges

Uncover why it's time to elevate the laboratory as a key part of the value-based healthcare solution.

Chapter 4

The Way Forward

Understand the necessity for change in healthcare and the key takeaways required for success.

Hear from the author

Find out now if you are asking the right questions about your laboratory from author David Humphreys, Practice Head of Health Policy and Clinical Evidence at the Economist Intelligence Unit.

Author video preview
Explore

Alinity Systems

Discover how Alinity uses technology to redefine and improve operational productivity and confidence in your laboratory.

Get to know alinity

Article: Total Value Ownership

Read how three laboratories from around the world used the Total Value of Ownership methodology to help reach their goals.

Read the article

Knowledge Center

Find the latest information in laboratory science, therapeutic areas and Abbott innovation.

Visit the knowledge center
Logo Image

©2023 Abbott, Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

All ARCHITECT analyzers, Alinity hq, CELL-DYN Ruby, CELL-DYN Sapphire and CELL-DYN Emerald 22 AL instruments are Class I laser products. ACCELERATOR APS and ACCELERATOR a3600 are Class II laser products.

The Alinity, ARCHITECT, ACCELERATOR and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin (blood, urine). Read the instructions in the system manuals and labeling and/or reagent instructions carefully. Manufacturer or Authorized Representative: Abbott Germany.

This website contains general information about our products sold worldwide. Product availability varies by country. For product availability in your country, please contact your local Abbott representative. Certain products described or certain features of some products described on this global page might not be commercially available in your country. Content is intended for healthcare professionals only.

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

NO